Using natural machinery to create new medicines
Harnessing Polyketide Assembly Lines for Medicinal Chemistry
This study is exploring how to tweak natural systems in bacteria to create new medicines, like antibiotics and cancer treatments, which could lead to better options for patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11089545 on NIH RePORTER |
What this research studies
This research focuses on harnessing natural polyketide assembly lines, which are biological systems that produce complex molecules with medicinal properties. By manipulating the DNA of these systems and understanding their assembly logic, the researchers aim to engineer new compounds that could serve as antibiotics or cancer treatments. The approach involves a combination of bioinformatics and synthetic biology to enhance the production of these valuable compounds in bacteria. Patients may benefit from new and more effective medications developed through this innovative process.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections or cancer who may benefit from novel therapeutic agents.
Not a fit: Patients with conditions that do not involve bacterial infections or cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics and cancer drugs that are more effective and have fewer side effects.
How similar studies have performed: Other research has shown promise in utilizing natural biosynthetic pathways for drug development, indicating that this approach could yield significant advancements.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Keatinge-Clay, Adrian Tristan — University of Texas at Austin
- Study coordinator: Keatinge-Clay, Adrian Tristan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.